ClinicalThought

Share

Program Content

Activities

  • ASH 2018: CAR-T
    CAR T-Cell Therapy in Lymphomas and Acute Lymphoblastic Leukemia: Exciting Data From ASH 2018
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 29, 2019

    Expires: April 27, 2020

Faculty

cover img faculity

Daniel J. DeAngelo, MD, PhD

Professor of Medicine
Harvard Medical School
Chief, Division of Leukemia
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

AbbVie

AstraZeneca

Celgene

Dova Pharmaceuticals

Gilead Text

Incyte

Janssen Biotech Pharmacyclics Abbvie

Jazz Pharmaceuticals, Inc.

Novartis Pharmaceuticals Corporation

Seagen

Takeda Oncology